1. Home
  2. RILYP vs BCTXZ Comparison

RILYP vs BCTXZ Comparison

Compare RILYP & BCTXZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RILYP

B. Riley Financial Inc.

N/A

Current Price

$16.20

Market Cap

0.0

Sector

Finance

ML Signal

N/A

Logo BriaCell Therapeutics Corp. Warrant

BCTXZ

BriaCell Therapeutics Corp. Warrant

N/A

Current Price

$0.07

Market Cap

0.0

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
RILYP
BCTXZ
Founded
1973
N/A
Country
United States
Canada
Employees
1380
4
Industry
Investment Managers
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RILYP
BCTXZ
Price
$16.20
$0.07
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
10.6K
87.1K
Earning Date
01-01-0001
N/A
Dividend Yield
7.03%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$854,383,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.00
$0.06
52 Week High
$17.52
$1.07

Technical Indicators

Market Signals
Indicator
RILYP
BCTXZ
Relative Strength Index (RSI) 57.27 45.51
Support Level $8.35 $0.06
Resistance Level $17.49 $0.09
Average True Range (ATR) 0.57 0.01
MACD -0.22 0.00
Stochastic Oscillator 46.03 75.65

Price Performance

Historical Comparison
RILYP
BCTXZ

About RILYP B. Riley Financial Inc.

BRC Group Holdings Inc is a diversified holding company offering a platform of businesses, including financial services, telecom, retail, and investments in equity, debt, and venture capital. It serves retail, corporate, capital providers, and individual customers across various business lines. The Group has seven reportable business segments: Capital Markets, Wealth Management, Lingo, magicJack, Marconi Wireless, UOL, and Consumer Products. Maximum revenue is generated from the Capital Markets segment, which provides investment banking and institutional brokerage services, offers loans, trades in equity securities, and maintains an investment portfolio of public and private equities and debt securities. Geographically, the Group derives maximum revenue from its business in North America.

About BCTXZ BriaCell Therapeutics Corp. Warrant

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

Share on Social Networks: